Pan-cancer analyses of clinical prognosis, immune infiltration, and immunotherapy efficacy for TRPV family using multi-omics data.

Heliyon · 2023 · PMC10279839 · PMID 37346342

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

borderline significanceno p-value reported

In addition, p value of TRPV4 low expression in bladder cancer and respond to immunotherapy was close to 0.05, had borderline significance.

also in 7,017 other papers

a significant trendno p-value reported

Our analysis shows that TRPV2 had a significant trend in transcription, genetic changes, and the association with immune infiltration and immune cells.

also in 9,775 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.